IRADIMED CORPORATION
iradimed.comWhat Do They Do?
Sells MRI-compatible infusion pumps, patient vital signs monitors and metal-detection devices for MRI safety to hospitals and acute care facilities.
10-K for FY2025, filed Mar 6, 2026IRADIMED CORPORATION (“IRadimed”, the “Company,” “we,” “us,” “our” or similar terms) develops, manufactures, markets and distributes…View ↗
We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use…View ↗
Our 3880 MRI compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to…View ↗
We sell our products primarily to hospitals and acute care facilities, both in the United States and internationally. We currently employ a…View ↗
In 2022, we introduced our ferromagnetic detection device (“FMD”), IRadimed FMD1 3600 with Remote Alarm Logging Unit, (“RALU”). This is the…View ↗
How Do They Make Money?
Hospitals and acute care facilities buy devices, disposables and related services; U.S. customers typically pay within 45 days after transfer, while international distributors pay part in advance and the balance within 30 days of receiving products. Extended maintenance is provided over agreements lasting one to four years.
10-K for FY2025, filed Mar 6, 2026We generate revenue from the sale of MRI compatible medical devices and accessories, extended maintenance agreements, services related to…View ↗
We recognize revenue when all of the following criteria are met: we have a contract with a customer that creates enforceable rights and…View ↗
Customer sale prices for our medical devices and related disposables and services are contractually fixed over the contract term. We…View ↗
Our deferred revenue consists of advance payments received from customers prior to the transfer of products or services, shipments that are…View ↗
$83.8M
-
10-K for FY2025, filed Mar 6, 2026
$83.8M ↗
Who Are Their Customers?
U.S. hospitals and acute care facilities buy directly through IRadimed’s sales force; internationally, independent distributors sell products to end users. Group purchasing organizations arrange negotiated pricing for member hospitals, which purchase directly from IRadimed.
10-K for FY2025, filed Mar 6, 2026We sell our products primarily to hospitals and acute care facilities, both in the United States and internationally. We currently employ a…View ↗
We sell our MRI compatible products through our direct sales force in the U.S. and independent distributors internationally. In the U.S.…View ↗
The principal customers for our MRI compatible products include hospitals and acute care facilities with MR equipment on site. The key…View ↗
GPO agreements enable us to sell and distribute our products to their member hospitals. Our agreements with GPOs typically include…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 27 cents of every revenue dollar as net income in FY2025 and turned 21 cents into free cash flow.
10-K for FY2025, filed Mar 6, 2026
$26.1MView ↗
10-K for FY2025, filed Mar 6, 2026
$22.5MView ↗
10-K for FY2025, filed Mar 6, 2026
$17.2MView ↗
How Are They Changing?
Growing. Revenue grew 2.0x in 4 years, from $41.8M in FY2021 to $83.8M in FY2025, about 19% a year.
Infusion pump lineup
The latest report introduces a new infusion pump and phases out sales of the previous model, while warranty and technical support continue.
10-K for FY2022, filed Mar 2, 2023 10-K for FY2025, filed Mar 6, 2026We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use…View ↗
Who Do They Compete With?
Competes with B. Braun, Fresenius Kabi, MIPM Mammendorfer Institut für Physik und Medizin, Invivo Research, GE Healthcare Technologies, and Schiller
10-K for FY2025, filed Mar 6, 2026We also compete with manufacturers of “shielded box” solutions that are intended as “workarounds” to permit use of conventional IV pumps…View ↗
Loading...
